Effects of a Consensus-Based Pulmonary Embolism Treatment Algorithm and Response Team on Treatment Modality Choices, Outcomes, and Complications.

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Roman MelamedNedaa Skeik

Abstract

Pulmonary embolism (PE) treatment depends on disease severity and risk of complications. Physician and institutional expertise may influence the use of reperfusion therapy (RT) such as systemic thrombolysis (SL) and catheter-directed interventions (CDI). We aimed to investigate the effects of a consensus-based treatment algorithm (TA) and subsequent implementation of PE response team (PERT) on RT modality choices and patient outcomes. A cohort of PE patients admitted to a tertiary care hospital between 2012 and 2017 was retrospectively evaluated. Demographics, clinical variables, RT selections, and patient outcomes during 3 consecutive 2-year periods (baseline, with TA, and with TA+PERT) were compared. Descriptive statistics were used for data analysis. A total of 1105 PE patients were admitted, and 112 received RT. Use of RT increased from 4.7% at baseline to 8.2% and 16.1% during the TA and TA+PERT periods. The primary RT modality transitioned from CDI to SL, and reduced-dose SL became most common. Treatment selection patterns remained unchanged after PERT introduction. Hospital length of stay decreased from 4.78 to 2.96 and 2.81 days (P < .001). Most of the hemorrhagic complications were minor, and their rates were similar a...Continue Reading

References

Oct 11, 2002·The New England Journal of Medicine·Stavros KonstantinidesUNKNOWN Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Jul 16, 2005·American Journal of Respiratory and Critical Care Medicine·Drahomir AujeskyMichael J Fine
Aug 11, 2010·Archives of Internal Medicine·David JiménezUNKNOWN RIETE Investigators
Mar 23, 2011·Circulation·Michael R JaffUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology
Feb 14, 2012·The American Journal of Medicine·Paul D Stein, Fadi Matta
Oct 30, 2012·The American Journal of Cardiology·Mohsen SharifiMahshid Mehdipour
Apr 11, 2014·The New England Journal of Medicine·Guy MeyerUNKNOWN PEITHO Investigators
May 8, 2015·Current Treatment Options in Cardiovascular Medicine·Nosheen Reza, David M Dudzinski
Jan 1, 2016·Circulation·David M Dudzinski, Gregory Piazza
Mar 1, 2016·Current Treatment Options in Cardiovascular Medicine·Mohsen Sharifi
Aug 3, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Alfonso J TafurM Hassan Murad
Feb 17, 2017·Seminars in Respiratory and Critical Care Medicine·Victor F Tapson, David Jimenez
Aug 16, 2017·The American Journal of Cardiology·Brett J CarrollDuane S Pinto
Oct 17, 2017·Techniques in Vascular and Interventional Radiology·Victor F Tapson, Oren Friedman
Sep 23, 2018·Journal of Thrombosis and Thrombolysis·Rachel RosovskyChristopher Kabrhel
Oct 17, 2018·Current Opinion in Critical Care·Jason D Chodakowski, D Mark Courtney
May 19, 2019·Journal of Thrombosis and Thrombolysis·Colin WrightScott J Cameron
Jun 13, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Belinda Rivera-LebronUNKNOWN PERT Consortium
Aug 14, 2019·JAMA : the Journal of the American Medical Association·Behnood BikdeliHarlan M Krumholz
Sep 10, 2019·The American Journal of Cardiology·Pulkit ChaudhuryJohn R Bartholomew

❮ Previous
Next ❯

Software Mentioned

PERT
TA
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.